We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

72 hedge funds and large institutions have $179M invested in Precision BioSciences in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 6

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

14% more funds holding

Funds holding: 63 → 72 (+9)

0% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 17

0.06% less ownership

Funds ownership: 1.46% → 1.4% (-0.06%)

39% less capital invested

Capital invested by funds: $291M → $179M (-$113M)

Holders
72
Holders Change
+9
Holders Change %
+14.29%
% of All Funds
1.58%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
17
Increased
17
Reduced
17
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$1.51M
2
BlackRock
BlackRock
New York
+$968K
3
WMSA
Weiss Multi-Strategy Advisers
New York
+$868K
4
Northern Trust
Northern Trust
Illinois
+$832K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$798K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$4.48M
2
VC
Vivo Capital
California
-$3.72M
3
Wells Fargo
Wells Fargo
California
-$2.71M
4
KCM
Kornitzer Capital Management
Kansas
-$2.61M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$424K +$27K +83 +5%
Squarepoint
27
Squarepoint
New York
$351K +$454K +1,394 New
Barclays
28
Barclays
United Kingdom
$327K -$13.7K -42 -3%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$281K +$149K +457 +69%
PPA
30
Parametric Portfolio Associates
Washington
$269K -$30.9K -95 -8%
Citadel Advisors
31
Citadel Advisors
Florida
$267K -$413K -1,269 -54%
ECM
32
ExodusPoint Capital Management
New York
$254K +$328K +1,009 New
Goldman Sachs
33
Goldman Sachs
New York
$180K +$8.79K +27 +4%
BFM
34
Boothbay Fund Management
New York
$168K -$211K -649 -49%
AllianceBernstein
35
AllianceBernstein
Tennessee
$130K +$168K +517 New
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$120K +$1.95K +6 +1%
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$116K +$150K +460 New
N
38
Nuveen
North Carolina
$114K – – –
Millennium Management
39
Millennium Management
New York
$113K +$146K +450 New
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$110K +$143K +438 New
IWM
41
IHT Wealth Management
Illinois
$93K +$120K +368 New
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$78K – – –
Federated Hermes
43
Federated Hermes
Pennsylvania
$59K +$76.2K +234 New
MA
44
MUFG Americas
New York
$55K +$29.9K +92 +72%
AIG
45
American International Group
New York
$49K -$325 -1 -0.5%
Morgan Stanley
46
Morgan Stanley
New York
$35K -$203K -623 -82%
UBS Group
47
UBS Group
Switzerland
$34K -$637K -1,956 -93%
EWM
48
Edge Wealth Management
New York
$33K – – –
Bank of America
49
Bank of America
North Carolina
$29K +$17.9K +55 +90%
Citigroup
50
Citigroup
New York
$25K -$31.6K -97 -49%
1
2
3 4

DTIL Hedge Fund Activity: Q3 2019 in Review

72 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q3 2019, worth a combined $179M — down 39% from $291M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new DTIL positions and 6 closed out — a net gain of 11 holders — while 17 added to existing stakes and 17 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $1.51M. The largest seller was Franklin Resources, cutting an estimated $4.48M.

  • 72 institutional investors held Precision BioSciences (DTIL) as of Q3 2019, up from 63 in Q2 2019.
  • Funds reported $179M of Precision BioSciences stock for Q3 2019, down 39% quarter-over-quarter.
  • 17 funds opened new Precision BioSciences positions in Q3 2019 and 6 closed out, a net change of +11 holders.
  • The largest Precision BioSciences buyer in Q3 2019 was Victory Capital Management, an estimated $1.51M added.
  • The largest Precision BioSciences seller in Q3 2019 was Franklin Resources, an estimated $4.48M sold.

Based on aggregated 13F filings for Q3 2019.